Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Distress Syndrome, Newborn | 6 | 2020 | 11 | 1.000 |
Why?
|
| Infant, Premature | 7 | 2021 | 141 | 0.990 |
Why?
|
| Nitric Oxide | 2 | 2019 | 152 | 0.840 |
Why?
|
| Infant, Newborn | 21 | 2021 | 885 | 0.790 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 2019 | 16 | 0.760 |
Why?
|
| Ductus Arteriosus, Patent | 3 | 2014 | 13 | 0.750 |
Why?
|
| Positive-Pressure Respiration | 1 | 2019 | 14 | 0.660 |
Why?
|
| Infant, Extremely Premature | 1 | 2019 | 12 | 0.650 |
Why?
|
| Resuscitation | 1 | 2019 | 59 | 0.630 |
Why?
|
| Intubation, Intratracheal | 2 | 2019 | 27 | 0.480 |
Why?
|
| Respiration, Artificial | 4 | 2010 | 41 | 0.450 |
Why?
|
| Intensive Care, Neonatal | 2 | 2010 | 17 | 0.400 |
Why?
|
| Indomethacin | 2 | 2010 | 15 | 0.380 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2010 | 25 | 0.380 |
Why?
|
| Ibuprofen | 2 | 2010 | 17 | 0.380 |
Why?
|
| Iatrogenic Disease | 1 | 2010 | 14 | 0.350 |
Why?
|
| Medication Errors | 1 | 2010 | 26 | 0.340 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2010 | 58 | 0.340 |
Why?
|
| Infant, Premature, Diseases | 2 | 2006 | 37 | 0.330 |
Why?
|
| Pulmonary Surfactants | 4 | 2020 | 11 | 0.320 |
Why?
|
| Hypoxia | 2 | 2006 | 89 | 0.320 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2009 | 13 | 0.320 |
Why?
|
| Bronchopulmonary Dysplasia | 4 | 2020 | 47 | 0.290 |
Why?
|
| Lysine | 1 | 2008 | 74 | 0.290 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 77 | 0.280 |
Why?
|
| Phospholipids | 3 | 2020 | 76 | 0.260 |
Why?
|
| Biological Products | 3 | 2020 | 65 | 0.250 |
Why?
|
| Premature Birth | 1 | 2006 | 57 | 0.250 |
Why?
|
| Humans | 22 | 2021 | 28094 | 0.250 |
Why?
|
| Double-Blind Method | 4 | 2020 | 417 | 0.240 |
Why?
|
| Administration, Inhalation | 2 | 2019 | 35 | 0.230 |
Why?
|
| Oxygen | 4 | 2020 | 233 | 0.220 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 2 | 2020 | 3 | 0.220 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 2 | 2020 | 6 | 0.220 |
Why?
|
| Phosphatidylcholines | 2 | 2020 | 45 | 0.210 |
Why?
|
| Peptide Fragments | 2 | 2020 | 202 | 0.190 |
Why?
|
| Time Factors | 2 | 2019 | 1591 | 0.190 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2021 | 23 | 0.180 |
Why?
|
| Infant | 4 | 2021 | 1004 | 0.180 |
Why?
|
| Enteral Nutrition | 1 | 2021 | 23 | 0.180 |
Why?
|
| Weight Gain | 1 | 2021 | 75 | 0.180 |
Why?
|
| Milk, Human | 1 | 2021 | 86 | 0.170 |
Why?
|
| Gestational Age | 2 | 2019 | 146 | 0.160 |
Why?
|
| Heart Rate | 2 | 2019 | 379 | 0.160 |
Why?
|
| Feasibility Studies | 1 | 2019 | 193 | 0.150 |
Why?
|
| Treatment Outcome | 4 | 2020 | 2377 | 0.150 |
Why?
|
| Pilot Projects | 1 | 2019 | 433 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2009 | 385 | 0.120 |
Why?
|
| Ligation | 2 | 2014 | 39 | 0.120 |
Why?
|
| Catecholamines | 1 | 2014 | 18 | 0.110 |
Why?
|
| Hypotension | 1 | 2014 | 19 | 0.110 |
Why?
|
| Hydrocortisone | 1 | 2014 | 89 | 0.110 |
Why?
|
| Ventilator Weaning | 2 | 2002 | 4 | 0.100 |
Why?
|
| Male | 8 | 2020 | 13489 | 0.100 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1992 | 4 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 1 | 1992 | 48 | 0.100 |
Why?
|
| Female | 9 | 2020 | 15153 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2014 | 173 | 0.090 |
Why?
|
| Parenteral Nutrition Solutions | 1 | 2010 | 2 | 0.090 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1991 | 31 | 0.090 |
Why?
|
| Risk Management | 1 | 2010 | 8 | 0.090 |
Why?
|
| Catheter-Related Infections | 1 | 2010 | 13 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 1 | 2010 | 49 | 0.090 |
Why?
|
| Catheters | 1 | 2010 | 24 | 0.090 |
Why?
|
| Kidney | 1 | 1992 | 286 | 0.090 |
Why?
|
| Retinopathy of Prematurity | 1 | 2010 | 38 | 0.090 |
Why?
|
| Cross Infection | 1 | 2010 | 37 | 0.080 |
Why?
|
| Health Education | 1 | 2010 | 71 | 0.080 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2010 | 44 | 0.080 |
Why?
|
| Length of Stay | 1 | 2010 | 229 | 0.080 |
Why?
|
| Research Design | 1 | 2010 | 184 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 300 | 0.070 |
Why?
|
| Lung | 1 | 2010 | 379 | 0.070 |
Why?
|
| Pleural Diseases | 1 | 1987 | 3 | 0.070 |
Why?
|
| Calcinosis | 1 | 1987 | 25 | 0.070 |
Why?
|
| Streptococcal Infections | 1 | 1987 | 36 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 1987 | 134 | 0.060 |
Why?
|
| Cerebral Hemorrhage | 1 | 2006 | 91 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 214 | 0.060 |
Why?
|
| Apnea | 3 | 1994 | 13 | 0.050 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2002 | 6 | 0.050 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 2002 | 5 | 0.050 |
Why?
|
| Respiration | 3 | 1991 | 45 | 0.050 |
Why?
|
| Oximetry | 2 | 2010 | 10 | 0.040 |
Why?
|
| Surface-Active Agents | 1 | 2020 | 44 | 0.040 |
Why?
|
| Radionuclide Imaging | 2 | 1992 | 56 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2014 | 2546 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 765 | 0.030 |
Why?
|
| Radiography | 2 | 1987 | 202 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2014 | 17 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2004 | 1248 | 0.030 |
Why?
|
| Monitoring, Physiologic | 2 | 1992 | 57 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1994 | 11 | 0.030 |
Why?
|
| Respiration Disorders | 1 | 1994 | 7 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2014 | 42 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2014 | 68 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2014 | 81 | 0.030 |
Why?
|
| Survival Rate | 1 | 2014 | 430 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 1994 | 111 | 0.020 |
Why?
|
| Fatty Alcohols | 1 | 1992 | 4 | 0.020 |
Why?
|
| Phosphorylcholine | 1 | 1992 | 11 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 612 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 887 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 1992 | 101 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1013 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 1994 | 185 | 0.020 |
Why?
|
| Pulmonary Ventilation | 1 | 1990 | 11 | 0.020 |
Why?
|
| Breath Tests | 1 | 1990 | 14 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2010 | 19 | 0.020 |
Why?
|
| Phenylisopropyladenosine | 1 | 1990 | 1 | 0.020 |
Why?
|
| Heart Rate, Fetal | 1 | 1990 | 2 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1990 | 92 | 0.020 |
Why?
|
| Adenosine | 1 | 1990 | 33 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 1990 | 79 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2014 | 611 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 452 | 0.020 |
Why?
|
| Incidence | 1 | 2010 | 562 | 0.020 |
Why?
|
| Heart | 1 | 1990 | 223 | 0.020 |
Why?
|
| Meningitis | 1 | 1987 | 11 | 0.020 |
Why?
|
| Streptococcus agalactiae | 1 | 1987 | 12 | 0.020 |
Why?
|
| Necrosis | 1 | 1987 | 85 | 0.020 |
Why?
|
| Suction | 1 | 2002 | 10 | 0.010 |
Why?
|
| Adolescent | 1 | 1987 | 3121 | 0.010 |
Why?
|
| United States | 1 | 2004 | 2146 | 0.010 |
Why?
|
| Pregnancy | 2 | 1994 | 1191 | 0.010 |
Why?
|
| Marijuana Abuse | 1 | 1994 | 14 | 0.010 |
Why?
|
| Amphetamines | 1 | 1994 | 11 | 0.010 |
Why?
|
| Cocaine | 1 | 1994 | 22 | 0.010 |
Why?
|
| Poisson Distribution | 1 | 1992 | 7 | 0.010 |
Why?
|
| Sudden Infant Death | 1 | 1992 | 3 | 0.010 |
Why?
|
| Lung Compliance | 1 | 1992 | 3 | 0.010 |
Why?
|
| Airway Resistance | 1 | 1992 | 4 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1992 | 27 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1992 | 50 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1992 | 210 | 0.010 |
Why?
|
| Electronics, Medical | 1 | 1990 | 3 | 0.010 |
Why?
|
| Nose | 1 | 1990 | 23 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1992 | 474 | 0.010 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 1990 | 1 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1990 | 8 | 0.010 |
Why?
|
| Bradycardia | 1 | 1990 | 17 | 0.010 |
Why?
|
| Caffeine | 1 | 1990 | 39 | 0.010 |
Why?
|
| Sheep | 1 | 1990 | 100 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1990 | 267 | 0.000 |
Why?
|
| Animals, Newborn | 1 | 1990 | 180 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1990 | 354 | 0.000 |
Why?
|
| Risk Factors | 1 | 1992 | 2081 | 0.000 |
Why?
|
| Adult | 1 | 1994 | 7739 | 0.000 |
Why?
|
| Animals | 1 | 1990 | 10415 | 0.000 |
Why?
|